|
US10584A
(en)
|
|
1854-02-28 |
|
Bank-lock |
|
US101A
(en)
|
|
1836-12-06 |
|
Method of jcakibtg and furling iw sails fob ships |
|
NZ333903A
(en)
|
1996-07-24 |
2000-02-28 |
Celgene Corp |
Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1oxoisoindolines and method of reducing TNF-alpha levels in a mammal
|
|
CA2287387C
(en)
|
1997-05-14 |
2010-02-16 |
Sloan-Kettering Institute For Cancer Research |
Methods and compositions for destruction of selected proteins
|
|
ES2241192T3
(es)
|
1997-12-17 |
2005-10-16 |
MERCK & CO., INC. (A NEW JERSEY CORP.) |
Antagonistas del receptor de integrina.
|
|
US6306663B1
(en)
|
1999-02-12 |
2001-10-23 |
Proteinex, Inc. |
Controlling protein levels in eucaryotic organisms
|
|
US6333344B1
(en)
|
1999-05-05 |
2001-12-25 |
Merck & Co. |
Prolines as antimicrobial agents
|
|
BR0111298A
(pt)
|
2000-06-28 |
2005-05-10 |
Bristol Myers Squibb Co |
Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
|
|
US7208157B2
(en)
|
2000-09-08 |
2007-04-24 |
California Institute Of Technology |
Proteolysis targeting chimeric pharmaceutical
|
|
US7041298B2
(en)
|
2000-09-08 |
2006-05-09 |
California Institute Of Technology |
Proteolysis targeting chimeric pharmaceutical
|
|
RU2298554C2
(ru)
|
2000-09-19 |
2007-05-10 |
Бристол-Маерс Сквибб Компани |
Конденсированные гетероциклические сукцинимидные соединения
|
|
US7091353B2
(en)
|
2000-12-27 |
2006-08-15 |
Celgene Corporation |
Isoindole-imide compounds, compositions, and uses thereof
|
|
US20030045552A1
(en)
|
2000-12-27 |
2003-03-06 |
Robarge Michael J. |
Isoindole-imide compounds, compositions, and uses thereof
|
|
CA2432932A1
(en)
|
2001-02-16 |
2002-08-29 |
Mark A. Scialdone |
Angiogenesis-inhibitory tripeptides, compositions and their methods of use
|
|
HN2002000136A
(es)
|
2001-06-11 |
2003-07-31 |
Basf Ag |
Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
|
|
PT1405621E
(pt)
|
2001-06-20 |
2011-05-31 |
Takeda Pharmaceutical |
Processo de prepara??o de comprimidos
|
|
WO2003014315A2
(en)
|
2001-08-06 |
2003-02-20 |
The Children's Medical Center Corporation |
Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
|
|
US7030141B2
(en)
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
WO2004020434A1
(ja)
|
2002-08-30 |
2004-03-11 |
Eisai Co., Ltd. |
含窒素芳香環誘導体
|
|
EP1781598A1
(en)
|
2004-07-08 |
2007-05-09 |
Warner-Lambert Company LLC |
Androgen modulators
|
|
CN100383139C
(zh)
|
2005-04-07 |
2008-04-23 |
天津和美生物技术有限公司 |
可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物
|
|
WO2006113942A2
(en)
|
2005-04-20 |
2006-10-26 |
Schering Corporation |
Method of inhibiting cathepsin activity
|
|
KR20080042158A
(ko)
|
2005-08-31 |
2008-05-14 |
셀진 코포레이션 |
이소인돌-이미드 화합물과 이를 포함하는 조성물 및 이를이용한 방법
|
|
BRPI0708524A2
(pt)
|
2006-03-03 |
2011-05-31 |
Novartis Ag |
compostos de n-formil hidroxilamina
|
|
KR101456722B1
(ko)
|
2006-03-29 |
2014-10-31 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴티오히단토인 화합물
|
|
JP2009544620A
(ja)
|
2006-07-20 |
2009-12-17 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
自己免疫疾患及び炎症のためのプロリン尿素ｃｃｒ１アンタゴニスト
|
|
RU2448101C2
(ru)
|
2006-08-30 |
2012-04-20 |
Селджин Корпорейшн |
5-замещенные изоиндолиновые соединения
|
|
US8877780B2
(en)
|
2006-08-30 |
2014-11-04 |
Celgene Corporation |
5-substituted isoindoline compounds
|
|
MX2009001989A
(es)
|
2006-08-30 |
2009-03-09 |
Celgene Corp |
Compuestos de isoindolina 5-substituidos.
|
|
CA2668286C
(en)
|
2006-11-03 |
2014-09-16 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
KR20100038108A
(ko)
|
2007-07-25 |
2010-04-12 |
브리스톨-마이어스 스큅 컴퍼니 |
트리아진 키나제 억제제
|
|
CN101820765A
(zh)
|
2007-07-31 |
2010-09-01 |
安德鲁科技有限公司 |
包含雄激素受体降解(ard)增强剂的组合物和预防性或治疗性治疗皮肤病与脱发的方法
|
|
PE20110547A1
(es)
|
2008-10-29 |
2011-08-04 |
Celgene Corp |
Compuestos de isoindolina con actividad anticancerigena
|
|
MX2011009053A
(es)
|
2009-03-09 |
2012-04-02 |
Spi Pharma Inc |
Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
|
|
WO2010141805A1
(en)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Heterocyclic amides as modulators of trpa1
|
|
JP2012532929A
(ja)
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二機能性のステープリングされたポリペプチドおよびそれらの使用
|
|
AR078793A1
(es)
|
2009-10-27 |
2011-12-07 |
Orion Corp |
Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
|
|
EP2536706B1
(en)
|
2010-02-11 |
2017-06-14 |
Celgene Corporation |
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
|
|
SG186389A1
(en)
|
2010-06-30 |
2013-01-30 |
Univ Brandeis |
Small-molecule-targeted protein degradation
|
|
EP2619184B1
(en)
|
2010-09-24 |
2018-05-23 |
The Regents of the University of Michigan |
Deubiquitinase inhibitors and methods for use of the same
|
|
AU2011338615B2
(en)
|
2010-12-07 |
2017-07-27 |
Yale University |
Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
|
|
US20140243282A1
(en)
|
2010-12-31 |
2014-08-28 |
Satish Reddy Kallam |
Methods and compositions for designing novel conjugate therapeutics
|
|
ES2541295T3
(es)
|
2011-04-21 |
2015-07-17 |
Orion Corporation |
Carboxamidas que modulan el receptor de andrógenos
|
|
CA2834535A1
(en)
|
2011-04-29 |
2012-11-01 |
Celgene Corporation |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
|
WO2013106646A2
(en)
|
2012-01-12 |
2013-07-18 |
Yale University |
Compounds and methods for the inhibition of vcb e3 ubiquitin ligase
|
|
CA2861066C
(en)
|
2012-01-12 |
2024-01-02 |
Yale University |
Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
|
|
US20140079636A1
(en)
|
2012-04-16 |
2014-03-20 |
Dinesh U. Chimmanamada |
Targeted therapeutics
|
|
US20150119435A1
(en)
|
2012-05-11 |
2015-04-30 |
Yale University |
Compounds useful for promoting protein degradation and methods using same
|
|
JO3754B1
(ar)
*
|
2012-06-04 |
2021-01-31 |
Pharmacyclics Llc |
أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون
|
|
CA2879454A1
(en)
|
2012-07-19 |
2014-01-23 |
Drexel University |
Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
|
|
GB201311910D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel Compounds
|
|
NL2011274C2
(en)
|
2013-08-06 |
2015-02-09 |
Illumicare Ip B V 51 |
Groundbreaking platform technology for specific binding to necrotic cells.
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
EP3035938B1
(en)
|
2013-09-10 |
2020-08-19 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
IN2014MU00303A
(https=)
|
2014-01-28 |
2015-09-11 |
Cipla Ltd |
|
|
AU2015224576A1
(en)
|
2014-03-03 |
2016-09-22 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
US20160058872A1
(en)
|
2014-04-14 |
2016-03-03 |
Arvinas, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
AU2015247817C1
(en)
|
2014-04-14 |
2022-02-10 |
Arvinas Operations, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
TW201613916A
(en)
|
2014-06-03 |
2016-04-16 |
Gilead Sciences Inc |
TANK-binding kinase inhibitor compounds
|
|
US20160022642A1
(en)
|
2014-07-25 |
2016-01-28 |
Yale University |
Compounds Useful for Promoting Protein Degradation and Methods Using Same
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
EA038518B1
(ru)
|
2014-11-21 |
2021-09-09 |
Биохэйвен Фармасьютикал Холдинг Компани Лтд. |
Сублингвальный препарат рилузола
|
|
CN107406424B
(zh)
|
2014-12-18 |
2020-08-25 |
豪夫迈·罗氏有限公司 |
雌激素受体调节剂及其用途
|
|
JP6815318B2
(ja)
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
JP6817962B2
(ja)
|
2015-01-20 |
2021-01-20 |
アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． |
ターゲティングされたアンドロゲン受容体分解のための化合物および方法
|
|
US12312316B2
(en)
|
2015-01-20 |
2025-05-27 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
GB201504314D0
(en)
|
2015-03-13 |
2015-04-29 |
Univ Dundee |
Small molecules
|
|
US10730870B2
(en)
|
2015-03-18 |
2020-08-04 |
Arvinas Operations, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
GB201506871D0
(en)
|
2015-04-22 |
2015-06-03 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201506872D0
(en)
|
2015-04-22 |
2015-06-03 |
Ge Oil & Gas Uk Ltd |
Novel compounds
|
|
HUE054149T2
(hu)
|
2015-06-04 |
2021-08-30 |
Arvinas Operations Inc |
Proteolízis imid-alapú modulátorai és ezekkel kapcsolatos felhasználási eljárások
|
|
WO2016197114A1
(en)
|
2015-06-05 |
2016-12-08 |
Arvinas, Inc. |
Tank-binding kinase-1 protacs and associated methods of use
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2017011371A1
(en)
|
2015-07-10 |
2017-01-19 |
Arvinas, Inc |
Mdm2-based modulators of proteolysis and associated methods of use
|
|
CA2988436A1
(en)
|
2015-07-13 |
2017-01-19 |
Arvinas, Inc. |
Alanine-based modulators of proteolysis and associated methods of use
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
AU2016349781A1
(en)
|
2015-11-02 |
2018-05-10 |
Yale University |
Proteolysis targeting chimera compounds and methods of preparing and using same
|
|
KR101859074B1
(ko)
|
2016-01-28 |
2018-05-18 |
이화여자대학교 산학협력단 |
신규한 글라이신 아미드 화합물 또는 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 포함하는 소듐 채널 활성 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
US20170281784A1
(en)
|
2016-04-05 |
2017-10-05 |
Arvinas, Inc. |
Protein-protein interaction inducing technology
|
|
JP6936498B2
(ja)
|
2016-04-21 |
2021-09-15 |
バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ， ＬＬＣ |
抗アポトーシス性Ｂｃｌ−２ファミリータンパク質の分解を誘導する化合物及びその使用
|
|
WO2017185031A1
(en)
|
2016-04-22 |
2017-10-26 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of use
|
|
CN109311869B
(zh)
|
2016-04-22 |
2022-12-23 |
达纳－法伯癌症研究所公司 |
通过细胞周期蛋白-依赖性激酶8(cdk8)抑制剂与e3连接酶配体的缀合降解cdk8和使用方法
|
|
WO2017197056A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
CN109790143A
(zh)
|
2016-05-10 |
2019-05-21 |
C4医药公司 |
用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
|
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
|
WO2018053354A1
(en)
|
2016-09-15 |
2018-03-22 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
WO2018071606A1
(en)
|
2016-10-11 |
2018-04-19 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
CA3042301A1
(en)
|
2016-11-22 |
2018-05-31 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
|
|
FR3064633B1
(fr)
|
2017-03-28 |
2019-04-12 |
Ecole Polytechnique |
Nouveaux composes de type dithiospirocetals et leur utilisation
|
|
AU2018261331C1
(en)
|
2017-05-01 |
2022-08-04 |
Spg Therapeutics, Inc. |
Tripartite androgen receptor eliminators, methods and uses thereof
|
|
KR102119465B1
(ko)
|
2017-09-20 |
2020-06-08 |
(주)아모레퍼시픽 |
트리메톡시 페닐 화합물 및 그를 포함하는 발모 또는 육모 촉진용 조성물
|
|
CN110746399B
(zh)
|
2018-07-23 |
2022-04-22 |
上海美志医药科技有限公司 |
具有降解雄激素受体活性的化合物
|
|
WO2020047487A1
(en)
|
2018-08-31 |
2020-03-05 |
The Regents Of The University Of California |
Methods for treating cancer with rorgamma inhibitors and statins
|
|
PL3897636T3
(pl)
|
2018-12-19 |
2025-04-28 |
Celgene Corporation |
Podstawione związki 3-((3-aminofenylo)amino)piperydyno-2,6-dionu, ich kompozycje i sposoby leczenia nimi
|
|
US11325889B2
(en)
|
2018-12-19 |
2022-05-10 |
Celgene Corporation |
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
|
|
CN120698983A
(zh)
|
2018-12-20 |
2025-09-26 |
C4医药公司 |
靶向蛋白降解
|
|
JP7555938B2
(ja)
|
2019-01-30 |
2024-09-25 |
モンテリノ・セラピューティクス・インコーポレイテッド |
アンドロゲン受容体を標的とするユビキチン化のための二官能性化合物および方法
|
|
US11547759B2
(en)
|
2019-01-30 |
2023-01-10 |
Montelino Therapeutics, Inc. |
Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
|
|
WO2020198712A1
(en)
|
2019-03-28 |
2020-10-01 |
Essa Pharma, Inc. |
Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
|
|
AU2020247255A1
(en)
|
2019-03-28 |
2021-11-11 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for use as Proteolysis Targeting Chimera ligands
|
|
US12331061B2
(en)
|
2019-04-18 |
2025-06-17 |
Accutar Biotechnology Inc. |
Compounds having BET, estrogen receptor, and androgen receptor degradation activity and uses thereof
|
|
KR20220004100A
(ko)
*
|
2019-04-18 |
2022-01-11 |
하이노바 파마슈티컬스 인코포레이티드 |
안드로겐 수용체를 표적 분해하는 이중 기능성의 키메라 헤테로 고리 화합물 및 이의 용도
|
|
JP2022533147A
(ja)
|
2019-05-17 |
2022-07-21 |
ヒノバ ファーマシューティカルズ インコーポレイテッド |
芳香族アミン類のａｒ及びｂｅｔを標的とするタンパク質分解キメラ化合物及び使用
|
|
US20220380368A1
(en)
|
2019-09-19 |
2022-12-01 |
The Regents Of The University Of Michigan |
Spirocyclic androgen receptor protein degraders
|
|
WO2021061644A1
(en)
|
2019-09-23 |
2021-04-01 |
Accutar Biotechnology Inc. |
Novel substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof
|
|
JP2022549222A
(ja)
|
2019-09-23 |
2022-11-24 |
アキュター バイオテクノロジー インコーポレイテッド |
アンドロゲン受容体分解活性を有する新規尿素およびその使用
|
|
US10836749B1
(en)
|
2019-09-23 |
2020-11-17 |
Accutar Biotechnology Inc. |
Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof
|
|
JP7716396B2
(ja)
|
2019-10-22 |
2025-07-31 |
アルビナス・オペレーションズ・インコーポレイテッド |
前立腺癌を治療する方法
|
|
CA3162523A1
(en)
|
2019-12-23 |
2021-07-01 |
Hongfu LU |
Protein degradation agent compound preparation method and application
|
|
CN113582974B
(zh)
|
2020-04-30 |
2022-05-17 |
江西济民可信集团有限公司 |
一类作为蛋白降解剂的化合物及其制备方法和医药用途
|
|
JP2023526055A
(ja)
|
2020-05-12 |
2023-06-20 |
アルビナス・オペレーションズ・インコーポレイテッド |
前立腺癌を治療する方法
|
|
CN113801098B
(zh)
|
2020-06-12 |
2023-05-30 |
上海济煜医药科技有限公司 |
酞嗪酮类化合物及其制备方法和医药用途
|
|
JP7778095B2
(ja)
|
2020-06-24 |
2025-12-01 |
セルジーン コーポレーション |
セレブロン結合化合物、その組成物及びそれによる治療方法
|
|
PE20231746A1
(es)
|
2020-06-24 |
2023-11-06 |
Celgene Corp |
Compuestos de union a cereblon, composiciones de estos y metodos de tratamiento con estos
|
|
KR20230027214A
(ko)
|
2020-06-24 |
2023-02-27 |
셀진 코포레이션 |
세레블론 결합 화합물, 이의 조성물, 및 이에 의한 치료 방법
|
|
CN113912589B
(zh)
|
2020-07-08 |
2023-10-20 |
北京泰德制药股份有限公司 |
抑制并诱导蛋白降解的化合物
|
|
WO2022048605A1
(zh)
|
2020-09-04 |
2022-03-10 |
南昌奥瑞药业有限公司 |
一种杂环化合物、其制备方法、中间体、组合物以及应用
|
|
CN114163444B
(zh)
|
2020-09-11 |
2023-07-14 |
江苏恒瑞医药股份有限公司 |
一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用
|
|
AU2021365850A1
(en)
|
2020-10-21 |
2023-06-08 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor protein
|
|
EP4240733A1
(en)
|
2020-11-06 |
2023-09-13 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor and associated methods of use
|
|
CN116529248B
(zh)
|
2020-11-25 |
2025-10-17 |
西藏海思科制药有限公司 |
一种苯环衍生物及其组合物和药学上的应用
|
|
KR20230118147A
(ko)
|
2020-12-11 |
2023-08-10 |
아비나스 오퍼레이션스, 인코포레이티드 |
전립선암 치료 방법
|
|
EP4023649A1
(en)
|
2020-12-30 |
2022-07-06 |
Industrial Technology Research Institute |
Androgen receptor binding bifunctional molecules
|
|
CN114853846A
(zh)
|
2021-02-04 |
2022-08-05 |
苏州国匡医药科技有限公司 |
一种雄激素受体降解剂及其应用
|
|
WO2022187419A1
(en)
|
2021-03-03 |
2022-09-09 |
The Regents Of The University Of Michigan |
Small molecule degraders of androgen receptor
|
|
US12016847B2
(en)
|
2021-03-12 |
2024-06-25 |
Bristol-Myers Squibb Company |
Methods of treating prostate cancer
|
|
CN116891457A
(zh)
|
2022-04-11 |
2023-10-17 |
江苏恒瑞医药股份有限公司 |
一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用
|
|
US20250248999A1
(en)
|
2022-04-21 |
2025-08-07 |
Arvinas Operations, Inc. |
Bavdegalutamide and combinations thereof for use in treating prostate cancer
|
|
CN117065033A
(zh)
|
2022-05-17 |
2023-11-17 |
海创药业股份有限公司 |
一种治疗三阴乳腺癌的联合用药物
|
|
CN117024390B
(zh)
|
2023-08-09 |
2025-11-11 |
中国海洋大学 |
一种Cdc20小分子配体化合物及其降解剂的应用
|